148 related articles for article (PubMed ID: 28036261)
1. Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.
Zhang ZZ; Chen Q; Kong CY; Li ZM; Wang LS
Oncotarget; 2017 Jan; 8(4):6623-6629. PubMed ID: 28036261
[TBL] [Abstract][Full Text] [Related]
2. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
[TBL] [Abstract][Full Text] [Related]
4. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
[TBL] [Abstract][Full Text] [Related]
6. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
[TBL] [Abstract][Full Text] [Related]
7. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
[TBL] [Abstract][Full Text] [Related]
8. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
[TBL] [Abstract][Full Text] [Related]
9. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V
BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
12. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
13. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer.
Wagner K; Arciaga R; Siperstein A; Milas M; Warshawsky I; Sethu S; Reddy K; Gupta MK
J Clin Endocrinol Metab; 2005 Apr; 90(4):1921-4. PubMed ID: 15687333
[TBL] [Abstract][Full Text] [Related]
15. Circulating thyroid cancer biomarkers: Current limitations and future prospects.
Nixon AM; Provatopoulou X; Kalogera E; Zografos GN; Gounaris A
Clin Endocrinol (Oxf); 2017 Aug; 87(2):117-126. PubMed ID: 28493290
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.
Barzon L; Boscaro M; Pacenti M; Taccaliti A; Palù G
Int J Cancer; 2004 Jul; 110(6):914-20. PubMed ID: 15170676
[TBL] [Abstract][Full Text] [Related]
17. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
18. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology.
Aliyev A; Patel J; Brainard J; Gupta M; Nasr C; Hatipoglu B; Siperstein A; Berber E
Surgery; 2016 Jan; 159(1):113-7. PubMed ID: 26454673
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies.
Davidson B
Virchows Arch; 2018 Oct; 473(4):395-403. PubMed ID: 30145616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
